MAM
ZBH icon

Madison Asset Management’s Zimmer Biomet ZBH Stock Holding History

Madison Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-56,650
Closed -$7.49M – 309
2020
Q3 		$7.49M Hold
56,650
– – 0.13% 125
2020
Q2 		$6.57M Hold
56,650
– – 0.12% 136
2020
Q1 		$5.56M Sell
56,650
-97,932
-63% -$12.8M 0.11% 139
2019
Q4 		$22.5M Buy
+154,582
New +$21.3M 0.35% 91

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Madison Asset Management's ZBH Position: Q4 2020 in Review

Madison Asset Management sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 56,650 shares — an estimated $7.49M sold.

Madison Asset Management first reported a position in ZBH in Q4 2019 and held it in 4 quarters. The position peaked at $22.5M in Q4 2019. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Madison Asset Management reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Madison Asset Management sold 56,650 Zimmer Biomet shares in Q4 2020, an estimated $7.49M.
  • Madison Asset Management first reported a position in Zimmer Biomet in Q4 2019 and held it in 4 quarters.
  • Madison Asset Management's Zimmer Biomet position peaked at $22.5M in Q4 2019.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Madison Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.